David M Lashen

Title: Innovations of David M Lashen

Introduction

David M Lashen is an accomplished inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for producing crystalline compounds. His work has implications for the production of important medicinal substances.

Latest Patents

David M Lashen holds a patent for a process for crystallizing a 4-azasteroid 5alpha-reductase inhibitor. This invention provides a method for producing crystalline 4,7.beta.-dimethyl-4-aza-5.alpha.-cholestan-3-one from 4,7.beta.-dimethyl-4-aza-5.alpha.-cholestan-3-one oil. The crystallization process involves controlled agitation and specific temperature management. Notably, this process has led to the discovery of at least two novel polymorphic nonsolvated forms of the compound, referred to as Form I and Form II.

Career Highlights

David M Lashen is associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to advancements in pharmaceutical processes and formulations. His innovative approach has been instrumental in enhancing the efficiency of drug production.

Collaborations

David has collaborated with notable colleagues, including Andrew L Forman and Sean R Holihan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

David M Lashen's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the industry positively.